26 results
PRE 14A
ABSI
Absci Corp
11 Apr 23
Preliminary proxy
5:49pm
matters to serve on the audit committee. Our board of directors has designated Ms. McGinnis as an “audit committee financial expert,” as defined under
8-K
EX-99.1
ABSI
Absci Corp
30 Mar 23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
4:10pm
.
Deepened Scientific Advisory Board with addition of in silico antibody design expert Dr. Victor Greiff, synthetic biology pioneer Dr. Timothy Lu
8-K
EX-3.1
zf2yg4k
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
DEF 14A
2d0tdk9mluvv66t nwfa
26 Apr 22
Definitive proxy
4:39pm
8-K
EX-3.2
uj76f
26 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B4
ig7bmmy0 r9lfdczc4ru
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
qxx74l1b4w
8 Jul 21
IPO registration (amended)
5:04pm
S-1
EX-10.12
yoursft0yfx8rzyaoyc
30 Jun 21
IPO registration
3:20pm
S-1
EX-3.3
01dbfq007ll5yoz
30 Jun 21
IPO registration
3:20pm
S-1
1jqxin
30 Jun 21
IPO registration
3:20pm
S-1
EX-10.11
rkq6 2i1eaugfd8i2
30 Jun 21
IPO registration
3:20pm
S-1
EX-10.1
sfy1qgtq1lsgsrv8w7l8
30 Jun 21
IPO registration
3:20pm